Biotechnology uses living organisms, cells and biological processes to create products and solve practical problems. This is a sector where scientific progress can become commercial opportunity across healthcare, agriculture, industry and environmental applications.
At its simplest, biotechnology applies biology to product development. This can include using microorganisms to produce medicines, improving crops through genetic techniques, developing diagnostic tools, or creating cleaner industrial processes. The common thread is the use of biological systems to improve how products are made, how diseases are treated, or how resources are managed.
Healthcare is one of the most visible areas of biotechnology. Companies in this space may work on new medicines, vaccines, gene therapies or diagnostic tests. These products can address clear market needs, particularly where existing treatments are limited.
Biotechnology also has relevance beyond medicine. In agriculture, it can help improve crop performance, increase resistance to pests and support more efficient food production. In industrial settings, biological processes can be used to make chemicals, materials and fuels in ways that may reduce waste or environmental impact.
Genflow Biosciences plc (LON:GENF, OTCQB:GENFF, FRA:WQ5) is a UK-based biotech firm with R&D facilities in Belgium focused on developing novel therapeutic approaches that potentially halt or slow the aging process in humans and dogs supporting longer, healthier lives
